A recent study found that during the 2018–2020 Ebola virus disease (EVD) outbreak in the eastern part of the Democratic Republic of the Congo (DRC), healthcare workers (HCWs) were very receptive to taking an experimental vaccine.
On July 25, 2023, the journal Frontiers published Original Research that found about 99% of HCWs received the Ervebo® Ebola Vaccine (rVSV-ZEBOV-GP, rVSV-ZEBOV, v920) live, recombinant, replication-competent vaccine during the DRC's 10 Ebola outbreak.
Ebola Vaccines Embraced by Healthcare Workers
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Mosquitoes Are Not Friendly
Over 125 years ago, a British doctor discovered that female Anopheles mosquitoes transmit malaria to humans. To commemorate this moment in history, World Mosquito Day (WMD) was founded.
Each year, WMD is an opportunity to raise awareness of the dangers posed by mosquito-borne diseases.
Today, mosquito-borne diseases kill more than one million people and infect up to 700 million yearly – almost one in ten people, says the WMD.
Malaria Arrives in Maryland
The Maryland Department of Health announced a positive case of locally acquired malaria in a person living in the National Capital Region. This new Maryland patient was hospitalized and is reported to be recovering.
This person did not travel recently outside the United States or visit Florida or Texas, where locally acquired malaria outbreaks have been reported.
Six, 12 Weeks of Cytisinicline Efficacious for Smoking Cessation
Cytisinicline well tolerated with only 2.9 percent of participants discontinuing due to an adverse event
WHO Monitoring Highly Mutated New Strain of COVID-19, Now Spotted in Michigan
Four known cases of the variant, dubbed BA.2.86, have so far been identified worldwide, including the case in Michigan
Better Responses Seen With Booster mRNA COVID-19 Vaccine in Pregnancy
Robust immune responses found after booster dose; efficient transplacental antibody transfer was seen
RSV Vaccine Now Available at Pharmacies
GSK plc today announced that AREXVY™, an approved Respiratory Syncytial Virus (RSV) vaccine, is now available at major retail pharmacies in the U.S.
AREXVY is currently indicated for preventing RSV-lower respiratory tract disease in individuals 60 years and older. An estimated 76.5 million people aged 60 and older in the U.S. may benefit from this RSV vaccine.
RSV is a seasonal disease, and an outbreak was recently in Florida
South Africa's Measles Outbreak Continues
Over the past year, the Republic of South Africa has been confronted with a significant measles outbreak. Even with an aggressive vaccination program, new measles cases continue to be reported.
As of August 16, 2023, the National Institute for Communicable Diseases (NICD) has tested 6,616 serum samples for measles since epidemiological week 40, 2022, of which 1124 (17%) were confirmed positive.
Recently, the percentage of samples testing positive decreased to 9% in week #31.
Pandemic Tied to Greater Weight Gain in Youths 10 to 12 Years Old
Effects of the pandemic on weight gain were most pronounced in low-income youth